Chung Elaine Y, Kim Sun Jung, Ma Xiao Jing
Department of Microbiology and Immunology, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021, USA.
Cell Res. 2006 Feb;16(2):154-61. doi: 10.1038/sj.cr.7310021.
Loss of self-tolerance and expansion of auto-reactive lymphocytes are the basis for autoimmunity. Apoptosis and the rapid clearance of apoptotic cells by phagocytes usually occur as coordinated processes that ensure regulated cellularity and stress response with non-pathological outcomes. Defects in clearance of apoptotic cells would contribute to the generation of self-reactive lymphocytes, which drive autoimmune disorders such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The IL-12 family of cytokines (IL-12, IL-23, and IL-27) and IL-10 are produced by phagocytic macrophages and play critical roles in the regulation of antigen-presenting cells (APCs) and effector lymphocytes during an immune response to pathogens. Inappropriate expression of these cytokines and their dysregulated activities have been strongly implicated in the pathogenesis of several autoimmune diseases. The production of pro- and anti-inflammatory cytokines by phagocytic APCs is delicately regulated during the ingestion of apoptotic cells as part of an intrinsic mechanism to prevent inflammatory autoimmune reactions. How apoptotic cell-derived signals regulate cytokine production is poorly understood. A recent study by our group demonstrated that phagocytosis of apoptotic cells by activated macrophages results in strong inhibition of IL-12 p35 gene expression by activating a novel transcription repressor, which we named GC-binding protein (GC-BP), through tyrosine dephosphorylation. We are also beginning to understand the molecular mechanisms underlying apoptotic cell-triggered production of IL-10 by phagocytes. These studies will help to elucidate some novel immune regulatory mechanisms and explore the regulation of immune responses to autoantigens with potentials to discover new therapeutic targets for the treatment of autoimmune disorders.
自身耐受性的丧失和自身反应性淋巴细胞的扩增是自身免疫的基础。凋亡以及吞噬细胞对凋亡细胞的快速清除通常作为协调过程发生,这些过程确保细胞数量的调节和应激反应,并产生非病理性结果。凋亡细胞清除缺陷会导致自身反应性淋巴细胞的产生,从而引发类风湿性关节炎(RA)和系统性红斑狼疮(SLE)等自身免疫性疾病。细胞因子IL-12家族(IL-12、IL-23和IL-27)以及IL-10由吞噬性巨噬细胞产生,在病原体免疫反应期间对抗抗原呈递细胞(APC)和效应淋巴细胞的调节中发挥关键作用。这些细胞因子的不适当表达及其失调的活性与几种自身免疫性疾病的发病机制密切相关。作为预防炎症性自身免疫反应的内在机制的一部分,吞噬性APC在摄取凋亡细胞期间对促炎和抗炎细胞因子的产生进行精细调节。凋亡细胞衍生的信号如何调节细胞因子的产生尚不清楚。我们小组最近的一项研究表明,活化巨噬细胞对凋亡细胞的吞噬作用通过酪氨酸去磷酸化激活一种新的转录抑制因子(我们命名为GC结合蛋白(GC-BP)),从而强烈抑制IL-12 p35基因的表达。我们也开始了解吞噬细胞凋亡细胞触发产生IL-10的分子机制。这些研究将有助于阐明一些新的免疫调节机制,并探索对自身抗原的免疫反应调节,有可能发现治疗自身免疫性疾病的新治疗靶点。